[Ovarian cancer treatment from the standpoint of the gynecologic oncologist]. 2007

Toru Sugiyama, and Akira Yoshizaki, and Shinya Hatayama
Dept. of Obstetrics and Gynecology, Iwate Medical University School of Medicine.

Ovarian cancer treatment on the standpoint of the gynecologic oncologist: Ovarian cancer is comprehensively treated with combined surgery and anticancer chemotherapy, which influence each other. In the initial surgery, a cancer stage is decided, and in advanced cancer, primary debulking surgery is conducted. The outcome of postoperative chemotherapy has a correlation with the diameter of the postoperative residual tumor. Recently, a new treatment strategy of interval debulking surgery during chemotherapy has been widely conducted to completely remove tumors. Improved diagnostic imaging such as PET enhances aggressive surgery for recurrent cancer.

UI MeSH Term Description Entries
D007044 Hysterectomy Excision of the uterus. Hysterectomies
D007258 Informed Consent Voluntary authorization, by a patient or research subject, with full comprehension of the risks involved, for diagnostic or investigative procedures, and for medical and surgical treatment. Consent, Informed
D009367 Neoplasm Staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. Cancer Staging,Staging, Neoplasm,Tumor Staging,TNM Classification,TNM Staging,TNM Staging System,Classification, TNM,Classifications, TNM,Staging System, TNM,Staging Systems, TNM,Staging, Cancer,Staging, TNM,Staging, Tumor,System, TNM Staging,Systems, TNM Staging,TNM Classifications,TNM Staging Systems
D009373 Neoplasms, Germ Cell and Embryonal Neoplasms composed of primordial GERM CELLS of embryonic GONADS or of elements of the germ layers of the EMBRYO, MAMMALIAN. The concept does not refer to neoplasms located in the gonads or present in an embryo or FETUS. Germ Cell Cancer,Germ Cell Tumor,Neoplasms, Embryonal and Mixed,Cancer, Embryonal,Cancer, Embryonal and Mixed,Embryonal Neoplasms,Germ Cell Neoplasms,Germ Cell and Embryonal Neoplasms,Germ Cell and Embryonic Neoplasms,Neoplasms, Embryonal,Neoplasms, Germ Cell,Neoplasms, Germ Cell and Embryonic,Cancer, Germ Cell,Cancers, Embryonal,Cancers, Germ Cell,Embryonal Cancer,Embryonal Cancers,Embryonal Neoplasm,Germ Cell Cancers,Germ Cell Tumors,Neoplasm, Embryonal,Tumor, Germ Cell,Tumors, Germ Cell
D010051 Ovarian Neoplasms Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS. Cancer of Ovary,Ovarian Cancer,Cancer of the Ovary,Neoplasms, Ovarian,Ovary Cancer,Ovary Neoplasms,Cancer, Ovarian,Cancer, Ovary,Cancers, Ovarian,Cancers, Ovary,Neoplasm, Ovarian,Neoplasm, Ovary,Neoplasms, Ovary,Ovarian Cancers,Ovarian Neoplasm,Ovary Cancers,Ovary Neoplasm
D001761 Bleomycin A complex of related glycopeptide antibiotics from Streptomyces verticillus consisting of bleomycin A2 and B2. It inhibits DNA metabolism and is used as an antineoplastic, especially for solid tumors. BLEO-cell,Blanoxan,Blenoxane,Bleolem,Bleomicina,Bleomycin A(2),Bleomycin A2,Bleomycin B(2),Bleomycin B2,Bleomycin Sulfate,Bleomycins,Bleomycinum Mack,Bléomycine Bellon,BLEO cell,BLEOcell,Bellon, Bléomycine,Mack, Bleomycinum,Sulfate, Bleomycin
D002945 Cisplatin An inorganic and water-soluble platinum complex. After undergoing hydrolysis, it reacts with DNA to produce both intra and interstrand crosslinks. These crosslinks appear to impair replication and transcription of DNA. The cytotoxicity of cisplatin correlates with cellular arrest in the G2 phase of the cell cycle. Platinum Diamminodichloride,cis-Diamminedichloroplatinum(II),cis-Dichlorodiammineplatinum(II),Biocisplatinum,Dichlorodiammineplatinum,NSC-119875,Platidiam,Platino,Platinol,cis-Diamminedichloroplatinum,cis-Platinum,Diamminodichloride, Platinum,cis Diamminedichloroplatinum,cis Platinum
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Toru Sugiyama, and Akira Yoshizaki, and Shinya Hatayama
June 2021, Journal of women's health (2002),
Toru Sugiyama, and Akira Yoshizaki, and Shinya Hatayama
May 2014, World journal of obstetrics and gynecology,
Toru Sugiyama, and Akira Yoshizaki, and Shinya Hatayama
November 1992, Gynecologic oncology,
Toru Sugiyama, and Akira Yoshizaki, and Shinya Hatayama
November 1993, Gynecologic oncology,
Toru Sugiyama, and Akira Yoshizaki, and Shinya Hatayama
June 2007, Obstetrics and gynecology,
Toru Sugiyama, and Akira Yoshizaki, and Shinya Hatayama
October 2002, Gynecologic oncology,
Toru Sugiyama, and Akira Yoshizaki, and Shinya Hatayama
January 2022, Gynecologic oncology,
Toru Sugiyama, and Akira Yoshizaki, and Shinya Hatayama
July 2007, Gan to kagaku ryoho. Cancer & chemotherapy,
Toru Sugiyama, and Akira Yoshizaki, and Shinya Hatayama
July 2007, Gan to kagaku ryoho. Cancer & chemotherapy,
Toru Sugiyama, and Akira Yoshizaki, and Shinya Hatayama
February 2023, JAMA network open,
Copied contents to your clipboard!